ARMP - Armata Pharmaceuticals, Inc. Forward P/S Multiple

Corporate company logo of Armata (ARMP)

Armata Pharmaceuticals sterile facilities are operating without interruption, ensuring precise biosynthesis for ongoing trials. The company occupies a unique niche by developing phage therapies against resistant bacteria, while the diversity of drug testing stages minimizes biotech risks. The expected P/S ratio provided by the GURU.Markets system demonstrates the market valuation of the business, where 24.90 shows the value of this parameter.

ARMP armatapharma.com: Market Cap to Expected Sales Ratio in the range 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for Armata (ARMP)

- current price and projected stock value:
Stock Price Armata Pharmaceuticals, Inc.|ARMP - Price Target Chart
- market capitalization statistics:
Market Capitalization Armata|ARMP - Total Enterprise Value
- issuer book value statistics:
Net Assets per Single Share Armata Pharmaceuticals|ARMP - Book Valuation of Business|Market Capitalization to Book Value Ratio armatapharma.com|ARMP - Company Total Assets
- debt and liquidity data:
Debt to Equity Armata Pharmaceuticals|ARMP - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Armata Pharmaceuticals|ARMP - Company Total Debt|Debts to Book Capitalization Armata|ARMP - Company Long-Term Debts|Company Current Liabilities Armata Pharmaceuticals|Quick Ratio armatapharma.com
- business earnings and investment ratios data:
ARMP - Net Profit|Future Profit Armata Pharmaceuticals|ARMP - Company Value to Net Income|Future Price to Earnings Armata Pharma|ARMP - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Armata|ARMP - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Armata Pharmaceuticals|ARMP - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months armatapharma.com|ARMP - Earnings per share increase in current year|Net earnings per share growth forecast for next year Armata Pharmaceuticals
- sales volume and revenue indicators:
ARMP - Company Sales|Projected Sales Volume Armata Pharmaceuticals, Inc.|ARMP - P/S Multiple|Forward P/S Multiple Armata
Analysis of all company metrics:Armata Pharmaceuticals, Inc. ARMP
Original product of Armata Pharmaceuticals

The development of innovative bacteriophages to combat antibiotic resistance is transitioning Armata Pharmaceuticals (ARMP) into a stage of intensive business scaling. The projected P/S ratio correlates current market capitalization with expected sales, allowing for an assessment of the market optimism currently priced in; while a high valuation confirms leadership potential, it creates a risk of correction should the company fail to meet its target revenue benchmarks.

Competitors of Armata Pharmaceuticals

Forward P/S Multiple ACXP (Acurx Pharmaceuticals, Inc.)